Clinical Trials
3
Active:1
Completed:1
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)VAL-1221 Delivered Intravenously in Ambulatory and Ventilator-free Participants With Late-Onset Pompe Disease
- First Posted Date
- 2016-09-13
- Last Posted Date
- 2020-06-02
- Lead Sponsor
- Valerion Therapeutics, LLC
- Target Recruit Count
- 12
- Registration Number
- NCT02898753
- Locations
- 🇺🇸
University of California, Irvine, Orange, California, United States
🇺🇸Duke University Medical Center, Durham, North Carolina, United States
🇬🇧National Hospital for Neurology and Neurosurgery, London, United Kingdom
Prospective, Longitudinal Study of the Natural History and Functional Status of Patients With Myotubular Myopathy (MTM)
Completed
- Conditions
- Myotubular Myopathy
- First Posted Date
- 2014-02-07
- Last Posted Date
- 2018-06-07
- Lead Sponsor
- Valerion Therapeutics, LLC
- Target Recruit Count
- 48
- Registration Number
- NCT02057705
- Locations
- 🇺🇸
Boston Children's Hospital, 300 Longwood Avenue, Boston, Massachusetts, United States
🇧🇪Centre Hospitalier Regional de la Citadelle, Liège, Belgium
🇨🇦Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, Canada
News
No news found